No description available.

No description available.

<p>Dissolved organic matter (DOM) in natural waters is a heterogeneous mixture of organic molecules with direct and indirect influences on aquatic organisms. Although the influences are usually attributed to DOM quantity (quantified as Dissolved Organic Carbon, DOC), the role of quality (optical and binding characteristics obtained by absorbance and fluorescence spectroscopy and potentiometric titration, respectively) is not well-understood. Through an initial critical review of the literature, followed by experimental geochemical, toxicological, and physiological investigations, a number of conclusions were reached that improve our knowledge in this area. Freshwater DOM sources exhibit source-dependent protection against metal toxicity, in particular copper (Cu). Generally, for this indirect effect, optically-dark terrestrially-derived or allochthonous DOMs offer better protection than microbially-derived or autochthonous sources. Linear regressions revealed that the better ameliorative effect is principally related to a higher aromatic composition (specific absorption coefficient, SAC₃₄₀) and a greater humic-like fluorescent component as quantified by parallel factor analysis (PARAFAC). In addition, the allochthonous DOMs were shown to have relatively higher magnitudes of titration index (TI), a new summary of chemical reactivity of DOM molecules obtained by titration analysis, and closely related to optical properties. TI was strongly correlated with SAC₃₄₀, suggesting greater binding capacities for DOM molecules with higher SAC₃₄₀. Consequently, a method for incorporation of SAC₃₄₀ as a DOM quality measure into the Biotic Ligand Model (BLM) was developed which improved Cu toxicity predictions in experimental tests with natural DOMs. For direct effects, two basic physiological functions (Na⁺ metabolism and nitrogen excretion) of the adult water flea (<em>Daphnia magna</em>, a cladoceran crustacean) and the zebrafish (<em>Danio </em><em>rerio</em>, a teleost fish) were investigated at circumneutral and acidic pH (≥ 7 and ~ 5, respectively). Three previously characterized, chemically-distinct natural DOM sources as well as a commercial humic acid (AHA) were examined. Regardless of the pH conditions, while Na⁺ regulation of <em>D</em>. <em>magna </em>remained unaffected by the presence of all DOMs, the passive diffusive efflux of Na⁺ in zebrafish was attenuated, indicating ameliorative action against unidirectional Na⁺ loss. In addition, only a distinct allochthonous-autochthonous DOM source stimulated the Na⁺ uptake rate of zebrafish at low pH. Ammonia excretion rates of <em>D</em>. <em>magna </em>were reduced at circumneutral pH by the most highly coloured, allochthonous DOM, and at low pH by all three natural DOMs. Both in <em>D. magna </em>and in <em>D. rerio</em>, urea excretion rates at both pH conditions were not influenced by the presence of the various DOMs, and the same was true for ammonia excretion in the zebrafish. A commercially prepared humic acid (Aldrich humic acid, AHA) exerted anomalous actions relative to those of natural DOMs, and does not appear to be representative of their normal effects. In contrast to the actions of DOM in detoxifying metals, these direct effects of DOMs on freshwater organisms appeared highly unpredictable with variable dependencies on the source, pH and species. This thesis has advanced our understanding of the relationships between DOM quality and its indirect and direct effects on aquatic organisms, and points to new directions for future work.</p> / Doctor of Philosophy (PhD)

Algumas atividades antrópicas podem provocar alterações nos recursos naturais, seja ela no rio, no solo ou no mar. Os efeitos destas alterações podem ser observados na biota, na qualidade das águas, na disponibilidade de nutrientes, interferindo em todos os elementos que compõem o ecossistema, influenciando-o em maior ou menor grau. O presente estudo procurou determinar o efeito dos poluentes sulfato de zinco, cloreto de amônia, dodecilsulfato de sódio e benzeno, numa espécie bioindicadora marinha, el larvas de mexilhão (Perna perna), além de acrescentar dados sobre a biologia e analisar quimicamente a presença de hidrocarbonetos nos tecidos dos animais adultos e das larvas. Para tanto foram utilizados testes de toxicidade, estudos sobre a bioenergética (consumo de oxigênio e excreção de amônia), enzimas biomarcadoras e excreção de fósforo e nitrogênio. Com relação à biologia, foram encontrados indivíduos sexualmente maduros a partir de 26,1 e 27 mm de comprimento para fêmeas e machos, respectivamente, e há diferença, ainda que esta não seja estatisticamente significativa, entre ovócitos e larvas submetidos a ação de poluentes. A análise de hidrocarbonetos indicou que existe uma contribuição biogênica e petrogênica no litoral norte do Estado de São Paulo. Para as demais análises verificou-se que, quando comparados aos grupos controles, as larvas foram sensíveis e responderam aos diferentes poluentes, geralmente com inibição da atividade. / Some antropic activities may be the cause fo alterations in natural resources, being it river, soil or sea. These alteration effects may be observed in the biota, water quality, nutrients disponibility, interfering with all elements that are part of a ecosystem, with greater or lesser influence degree. The present study was directed to determine the effect of pollutants, such as zinc sulphate, ammonia chlorate, sodium dodecilsulphate and benzene, acting over larvae of a marine bioindicator, the mussel (Perna perna), besides adding data on biology and chemically analysing hidrocarbon presence in larvae and adult animal tissues. In order to obtain these results, toxicity tests were used and bioenergetic (oxygen consumption and ammonia excretion), biomarkers, phosphorus and nitrogen excretion, were studied. As for biology, individuals sexually mature were found starting with 26,1 and 27 mm length females and males, respectively, and there is difference between larvae and ovocites, although statistically not significant, submitted to pollutants action. The hydrocarbon analysis indicates a biogenic and petrogenic contribution to north coast of São Paulo State. For the other analyses the observed results, when compared to control groups, showed that larvae are sensitive, and responded to different pollutants, generally with activity inhibition.

Introdução: A variação genética em genes que codificam a absorção, distribuição, metabolismo e excreção (ADME) de medicamentos frequentemente afeta a farmacocinética da droga e resulta na variabilidade da eficácia e segurança do medicamento. No entanto, a frequência da variação genética nos genes ADME diferem entre as populações. O objetivo deste estudo foi analisar as variações genéticas nos genes ADME nos pacientes brasileiros portadores do vírus da hepatite C e comparar com outros bancos de dados (1000 Genomes Project e Exome Aggregation Consortium). Métodos: Um total de 147 genes ADME foram genotipados em 100 amostras por sequenciamento de DNA genômico usando SureSelectXT (Agilent) e MiSeq, NextSeq (Illumina). Resultados: Um total de 2004 SNPs em 147 genes foram analisados, incluindo enzimas de fase I (n=50), enzimas de fase II (n=37) e transportadores (n=60). Uma coleção de variantes genéticas indica que há pelo menos 2 vezes mais variações do que semelhanças entre os pacientes com hepatite C e os principais grupos continentais. Estas diferenças foram observadas em vários genes relevantes, incluindo CYP1A2, CYP3A4, NAT2, ABCB1 e SLCO1B1. Além disso, pacientes auto declarados como branco, pardo, negro e asiático também apresentaram diferenças de frequência alélica quando comparados à europeus, americanos mixos, africanos e asiáticos nos polimorfismos dos genes CYP1A1, CYP2B6, GSTP1 e ABCG2, respectivamente. Conclusão: Concluímos que os pacientes com hepatite C tem uma frequência alélica de genes ADME diferente dos outros bancos de dados. Embora a personalização do tratamento medicamentoso com base no genótipo individual, e não na etnia, possa ser a mais apropriada, as diferenças nas frequências alélicas entre os continentes devem ser consideradas ao projetar ensaios clínicos de novos medicamentos / Background: Genetic variation in genes encoding drug absorption, distribution, metabolism, and excretion (ADME) proteins often affects the drug pharmacokinetics and results in variability in drug efficacy and safety. However, the frequency of genetic variation in the ADME genes differ among populations. The aim of this study was to analyze the genetic variations in the ADME genes in Brazilian patients with hepatitis C and to compare to other databases (1000 Genomes Project e Exome Aggregation Consortium). Methods: A total of 147 ADME were genotyped in 100 samples from Brazil by targeted genomic DNA sequencing using SureSelectXT (Agilent) and MiSeq, NextSeq (Illumina). Results: A total of 2004 SNPs in 147 genes that were analyzed, including phase I enzymes (n=50), phase II enzymes (n=37), drug transporters (n=60). We provide a collection of genetic variants that indicate that there are at least 2-times more variation than similarities between patients with hepatitis C and major continental groups. These differences were observed in several relevant genes including CYP1A2, CYP3A4, NAT2, ABCB1 and SLCO1B1. Moreover, white, brown, black and Asian self-reported patients also showed allele frequency differences when compared to European, mixed American, African and Asian for polymorphisms of the genes CYP1A1, CYP2B6, GSTP1 and ABCG2. respectively. Conclusion: We conclude that the hepatitis C patients has an allele frequency of ADME genes different from other data bases. While personalization of drug treatment based on individual genotype rather than ethnicity may be more appropriate, differences in allelic frequencies across continents should be considered when designing clinical trials of new drugs

Diese Studie untersucht die Bedeutung von Angiotensin II- und Endothelin-1-vermittelten Mechanismen, die im Rahmen von hämodynamischen, hormonellen und renalen Reaktionen bei einen akuten Blutverlust einsetzen. Es wurden wache Hunde mit und ohne Vorbehandlung mit Angiotensin II Typ 1 (AT1) und/oder Endothelin-A (ETA) Rezeptorblockern untersucht. Protokoll 1: Nach einer 60-minütigen Kontrollstunde wurde den Hunden 25% ihres Blutes zügig entzogen. Nach einer Stunde wurde das Blut retransfundiert und die Datenaufzeichnung für eine weitere Stunde fortgesetzt. Protokoll 2: Wie Protokoll 1, aber mit AT1 Blockade durch Losartan i.v. Protokoll 3: Wie Protokoll 1, aber mit ETA Blockade durch ABT-627 i.v. Protokoll 4: Wie Protokoll 1, aber mit kombinierter AT1 plus ETA Blockade. In der Kontrolle sinkt der arterielle Mitteldruck (MAP) nach dem Blutentzug um ~25%, das Herzzeitvolumen (HZV) um ~40%, das Urinvolumen um ~60%, während die Plasmakonzentrationen von Angiotensin II (3.1-fach), Endothelin-1 (1.13-fach), Vasopressin (116-fach) und Adrenalin (3.2-fach) ansteigen. Unter AT1 Blockade kommt es zu einem überproportionalen Abfall des arteriellen Mitteldrucks und die glomeruläre Filtrationsrate (GFR) sinkt. Beim Blutentzug unter ETA Blockade steigt Noradrenalin und nicht Adrenalin an, und der Wiederanstieg des MAP infolge Retransfusion ist unvollständig. In allen Protokollen sinkt das HZV um den gleichen Betrag. Schlussfolgerungen: Für die kurzfristige Regulation des Blutdrucks und die renale Autoregulation der GFR nach Blutverlust spielt Angiotensin II eine wichtigere Rolle als Endothelin-1. Andererseits ist ein intaktes Endothelinsystem eine wichtige Voraussetzung für die vollständige Restitution des arteriellen Mitteldrucks in der Retransfusionsphase. Darüber hinaus scheint Endothelin-1 nach dem Blutentzug die Freisetzung von Adrenalin zu erleichtern, die Freisetzung von Noradrenalin jedoch zu mildern. Die bei einem akuten Blutverlust einsetzenden Kompensationsmechanismen scheinen den Blutfluss (HZV) viel effektiver aufrecht zu erhalten als den Blutdruck (MAP), denn das HZV, nicht aber der arterielle Mitteldruck, sank in allen Protokollen um den gleichen Betrag. / This study investigates angiotensin II and endothelin-1 mediated mechanisms involved in the hemodynamic, hormonal, and renal response towards acute hypotensive hemorrhage. Conscious dogs were pretreated with angiotensin II type 1 (AT1) and/or endothelin-A (ETA) receptor blockers or not. Protocol 1. After a 60 min baseline period, 25% of the dog's blood was rapidly withdrawn. The blood was retransfused 60 min later and data recorded for another hour. Protocol 2. Likewise, but preceded by AT1 blockade with i.v. Losartan. Protocol 3. Likewise, but preceded by ETA blockade with i.v. ABT-627. Protocol 4. Likewise, but with combined AT1 plus ETA blockade. In Controls, hemorrhage decreased mean arterial pressure (MAP) by ~25%, cardiac output by ~40%, and urine volume by ~60%, increased angiotensin II (3.1-fold), endothelin-1 (1.13-fold), vasopressin (116-fold), and adrenaline concentrations (3.2-fold). Glomerular filtration rate and noradrenaline concentrations remained unchanged. During AT1 blockade, the MAP decrease was exaggerated (-40%) and glomerular filtration rate fell. During ETA blockade, noradrenaline increased after hemorrhage instead of adrenaline, and the MAP recovery after retransfusion was blunted. The decrease in cardiac output was similar in all protocols. Conclusions: Angiotensin II is more important than endothelin-1 for the short-term regulation of MAP and glomerular filtration rate after hemorrhage, whereas endothelin-1 seems necessary for complete MAP recovery after retransfusion. After hemorrhage, endothelin-1 seems to facilitate adrenaline release and to blunt noradrenaline release. Hemorrhage-induced compensatory mechanisms maintain blood flow more effectively than blood pressure, since the decrease in cardiac output - but not MAP - was similar in all protocols.

Faible masse musculaire a été peu étudiée chez les patients avant le stade terminal de la maladie rénale chronique (MRC). Nous avons évalué la masse musculaire à partir de la créatininurie des 24h pour étudier ses déterminants, son évolution avec le déclin de la fonction rénale ainsi que ses liens avec les risques de progression vers l’insuffisance rénale terminale traitée (IRTT) et de décès avant IRTT. Dans la cohorte NephroTest incluant 1429 patients avec une MRC stades 1 à 4, le débit de filtration glomérulaire a été mesuré par la clairance du 51Cr-EDTA (DFGm) et estimé par l’équation CKD EPI (DFGe). La créatininurie moyenne à l’inclusion diminuait de 15.3±3.1 à 12.1±3.3 mmol/24 chez les hommes et de 9.6±1.9 à 7.6±2.5 chez les femmes, pour une baisse du DFGm de ≥ 60 à < 15 mL/min/1.73 m2. Être plus âgé, avoir un diabète, un faible IMC ou un niveau faible de protéinurie et d’apports protidiques était associé à un niveau faible de créatininurie. Un déclin annuel du DFGm de 5 mL/min/1.73 m2 était lié à une baisse de créatininurie, indépendamment de ces déterminants. Au cours d’un suivi médian de 3.6 ans, 229 patients ont développé une IRTT, et 113 sont décédés avant IRTT. Après ajustement sur les facteurs de confusion, le hasard ratio (HR) était de 1.6 (0.88-2.9) pour le risque de décès et de 0.60 (0.39-0.91) pour le risque d’IRTT, dans le 1er vs 4ème quartile de créatininurie. La baisse de la créatininurie apparait précocement dans la MRC et est liée au décès avant dialyse. La diminution du risque d’IRTT pourrait s’expliquer par un démarrage plus tardif de la dialyse en raison d’une surestimation du DFGm par le DFGe chez les patients avec une faible créatininurie. / Mainly described in patients on dialysis, muscle wasting has received little attention in early stage chronic kidney disease (CKD). We used 24-hour creatininuria to assess determinants of low muscle mass and its putative associations with CKD outcomes, using data from the NephroTest cohort, including 1429 non-dialysis patients with CKD stages 1 to 5. Kidney function was assessed with both measured (mGFR, by 51Cr-EDTA renal clearance) and estimated glomerular filtration rate (eGFR, by CKD-EPI equation). End-stage renal disease (ESRD) and pre-ESRD death were the main studied outcomes. The mean baseline creatininuria decreased from 15.3±3.1 to 12.1±3.3 mmol/24 h in men and from 9.6±1.9 to 7.6±2.5 in women, when mGFR fell from ≥ 60 to < 15 mL/min/1.73 m2. Other determinants of low creatininuria were an older age, diabetes, a lower body mass index, a lower level of proteinuria or protein intake. A fast annual decline in mGFR of 5 mL/min/1.73 m2 was linked with a 2-fold decrease in creatininuria, independent of changes in protein intake and other determinants of muscle mass. Over a median follow-up of 3.6 years, 229 patients developed ESRD and 113 patients died before ESRD. After adjustment for confounders, patients with low muscle mass showed a significantly higher risk for pre-ESRD death (HR 1.6, 95% CI 0.88-2.9), but a lower risk for ESRD (HR 0.60, 95% CI 0.39-0.91). The latter was reversed (HR 1.5, 95% CI 1.01-2.4) when mGFR was replaced by eGFR. Decrease in 24-hour creatininuria may appear early in CKD patients, is related to pre-ESRD death. The lower risk for ESRD may reflect later dialysis start due to overestimation of true GFR by eGFR in patients with low muscle mass.

L’aflatoxine B1 (AFB1) et l’ochratoxine A (OTA) sont des mycotoxines pouvant contaminer une large variété de denrées alimentaires. L’ingestion d’aliments contaminés par des animaux d’élevage peut entraîner l’altération de leur santé et de leurs performances zootechniques ainsi qu’un problème de sécurité alimentaire lié à la présence de résidus de mycotoxines dans les produits animaux, notamment le lait. Des traitements de détoxication basés sur l’addition d’adsorbants organiques ont été développés pour fixer les mycotoxines dans le tube digestif et ainsi réduire l’exposition des animaux. L’objectif de ce travail de thèse était d’évaluer l’efficacité d’un adsorbant à base d’extraits de parois modifiées de levures (Mycosorb®) sur deux modèles animaux, le rat et la brebis. L’efficacité a été déterminée en réalisant un suivi des mycotoxines et/ou de leurs métabolites dans 3 matrices : l’excrétion urinaire et fécale et la cinétique sanguine. Sur les 2 modèles animaux, nous avons ainsi étudié les effets de l’apport en Mycosorb sur l’excrétion urinaire et fécale et la cinétique sanguine des 2 mycotoxines (AFB1 et OTA). Chez le rat, le suivi de la radioactivité a montré que les fèces d’animaux supplémentés en parois de levures contiennent significativement plus de mycotoxines. Cette augmentation de la radioactivité dans les fèces s’est accompagnée d’une diminution marquée de la radioactivité dans le sang et dans les urines. Chez la brebis laitière, en plus de ces paramètres, nous avons évalué l’effet de l’adsorbant sur les paramètres de production de l’animal et l’excrétion des mycotoxines dans le lait. L’addition de la paroi de levure a entraîné une augmentation significative de l’excrétion de l’AFB1 et de son métabolite, l’aflatoxine M1(AFM1) dans les fèces du ruminant. Cette augmentation de l’excrétion fécale s’accompagne de la réduction du taux d’AFM1 excrété dans l’urine mais pas dans le lait. Les effets observés chez les deux modèles expérimentaux semblent être liés à la séquestration des mycotoxines dans le tractus digestif des animaux et permettent de conclure à la capacité de l’adsorbant organique à réduire la biodisponibilité des mycotoxines testées. L’ajout de la paroi de levure pourrait, par conséquent, réduire les risques sanitaires chez les animaux d’élevage exposés à une alimentation contaminée par les mycotoxines. Cependant, nous n’avons pas observé d’effet sur la santé et les paramètres zootechniques des animaux dans les conditions expérimentales utilisées. / Aflatoxin B1 (AFB1) and Ochratoxin A (OTA) are mycotoxins that can be found in a large variety of feedstuffs. Consumption of contaminated feeds can affect the health and performances of farm animals and if transferred into animal products can be a problem for the safety of food. Different treatments of detoxication based on organic adsorbants addition have been developed to bind these mycotoxins in the digestive tract and thus to reduce exposure of animals. The objective of this work was to evaluate the efficacy of an adsorbent containing yeast cell wall extracts (Mycosorb®) in two animal models, the rat and the dairy ewe. The efficacy was determined by performing a monitoring of mycotoxins and/or theirs metabolites in 3 matrices : urinary and faecal excretion and blood kinetic. In both animal models, thus we have studied the effects of yeast cell walls on urinary and faecal excretion and blood kinetic of the 2 mycotoxins (AFB1 and OTA). Radioactivity analysis showed that faeces of animals supplemented with the adsorbent contained significantly more mycotoxins in rats. This increase of radioactivity in feces was associated with a marked decrease of radioactivity in blood and urine. In dairy ewes, in addition to these parameters, we have evaluated the effects of the adsorbent on the production parameters of animals and the excretion of mycotoxins in milk. The addition of yeast cell walls significantly increased the excretion of AFB1 and its metabolite, aflatoxin M1 (AFM1) in the faeces. This increase in fecal excretion was associated with a reduction of the excretion of AFM1 in urine but not in milk. The reduced absorption of AFB1 and OTA in both animal models could be associated with the capacity of the adsorbent to bind mycotoxins in the digestive tract. Addition of yeast cell wall extract could be a strategy to reduce sanitary risks in ruminants exposed to mycotoxins-contaminated feeds. However, we have not observed an effect on the health and the performances of animals in the experimental conditions used.

In vivo studies of hepatobiliary disposition are challenging. The hepatobiliary system is complex, as its physiological localization, complex cellular structure with numerous transporters and enzymes, and the interindividual variability in protein expression and biliary flow will all affect the in vivo disposition of a drug under investigation. The research included in this thesis has focused on the involvement of hepatic transport proteins in the hepatobiliary disposition of rosuvastatin. The impact that several transport inhibitors had on the pharmacokinetics of rosuvastatin was investigated in healthy volunteers and in pigs. The effects were considerable, following inhibition of sinusoidal transport proteins by cyclosporine and rifampicin. These inhibitors significantly reduced the hepatic extraction of rosuvastatin by 50 and 35%, respectively, and the plasma exposure increased by factors of 9.1 and 6.3, respectively. Drug-drug interactions (DDI) resulting in markedly higher plasma exposures are important from a drug safety perspective as increased extrahepatic exposure of statins is associated with an increased risk of severe side-effects, such as myopathy which in rare cases could develop into rhabdomyolysis. The DDI caused by cyclosporine and rifampicin can probably be attributed to inhibition of hepatic uptake transporters. In contrast, inhibition of canalicular transporters by imatinib did not significantly affect the pharmacokinetics of rosuvastatin, which suggests that the intracellular concentration of the inhibitor in the hepatocyte was insufficient to affect the transport of rosuvastatin, or that imatinib is not a sufficiently potent inhibitor in vivo. Furthermore, gemfibrozil administered as a single dose into the jejunum in healthy volunteers and pigs did not affect the plasma or biliary pharmacokinetics of rosuvastatin. The previously reported DDI in humans upon repeated dosing with gemfibrozil might be explained by the accumulation of metabolites able to affect the disposition of rosuvastatin. The investigations presented in this thesis conclude that transport proteins are of considerable importance for the hepatobiliary disposition of rosuvastatin in vivo. The Loc-I-Gut catheter can be applied for the investigation of biliary accumulation and to determine bile specific metabolites, however it has limitations when conducting quantitative measurements. In the porcine model, hepatic bile can be collected for up to six hours and enables the determination of the hepatic extraction in vivo.

A series of experiments were conducted to determine nutritional strategies to improve the efficiency of N utilization in dairy cows when feeding co-products including wheat-based (W-DDGS) and corn-wheat blend distillers grains with solubles (B-DDGS), and dried whey permeate (DWP). In Experiment 1, the objective was to determine the effects of replacing canola meal (CM) as the major protein source with W-DDGS on ruminal fermentation, microbial protein production, omasal nutrient flow, and animal performance. Cows were fed either a standard barley silage-based total mixed ration containing CM as the major protein supplement (0% W-DDGS, control) or diets formulated to contain 10, 15 and 20% W-DDGS (dry matter [DM] basis), with W-DDGS replacing primarily CM. Diets were isonitrogenous (18.9% crude protein [CP]). Inclusion of W-DDGS to the diet did not negatively affect ruminal fermentation, microbial protein production, and omasal nutrient flow. However, there was a 0.7- to 2.4-kg increase in DM intake, and a 1.2- to 1.8-kg increase in milk yield after the addition of W-DDGS in place of CM. In Experiment 2, the objective was to delineate the effects of including either W-DDGS or B-DDGS dried distillers grains with solubles as the major protein source in low or high CP diets fed to dairy cows on ruminal function, microbial protein synthesis, omasal nutrient flows, urea-N recycling, and milk production. The treatment factors were type of distillers co-product (W-DDGS vs. B-DDGS) and dietary CP content (15.2 vs. 17.3%; DM basis). The B-DDGS was produced from a mixture of 15% wheat and 85% corn grain. All diets were formulated to contain 10% W-DDGS or B-DDGS on a DM basis. Feeding up to 10% of dietary DM as B-DDGS or W-DDGS as the major source of protein did not have negative effects on metabolizable protein (MP) supply and milk production in dairy cows. However, reducing dietary CP content from 17.3 to 15.2% decreased milk production. This response was attributed to an insufficient supply of ruminally degradable protein (RDP) that suppressed microbial nonammonia N (NAN) synthesis in the rumen, thus decreasing intestinal MP supply. In Experiment 3, the objective was to determine the effects of replacing barley or corn starch with lactose (as DWP) in diets containing 10% W-DDGS on ruminal function, omasal nutrient flow, and lactation performance. The treatment factors were source of starch (barley vs. corn) and dietary inclusion level of DWP (0 vs. 6%; DM basis) as a partial replacement for starch. Diets were isonitrogenous (18% CP) and contained 3 or 8% total sugar. The starch content of the low sugar diet was 24% compared to 20% for the high sugar diet. Dry matter intake, and milk and milk component yields did not differ with diet. However, partially replacing dietary corn or barley starch with sugar up-regulated ruminal acetate and propionate absorption, and reduced ruminal NH3-N concentration, but had no effect on ruminal pH, microbial protein synthesis, omasal nutrient flow and production in dairy cows. In summary, data presented in this thesis indicate that W-DDGS and B-DDGS can be included as the major source of protein in dairy cow diets without compromising ruminal function, nutrient supply and milk production in dairy cows. Feeding medium to low CP diets, and partial replacement of starch with sugar in diets containing W-DDGS and B-DDGS can improve N utilization efficiency in dairy cows. Additionally, an upregulation of facilitated transport of acetate and propionate across epithelial cells possibly prevents the occurrence of ruminal acidosis when lactose partially replaces starch in cow diets.